Dec 05, 2018 - The approval from Takeda Pharmaceutical’s shareholders for the Shire bid clears the path for the biggest-ever overseas acquisition by a Japanese company.
Dec 03, 2018 - Shire's (SHPG) gets European approval for Takhzyro subcutaneous injection, for routine prevention of recurrent attacks of hereditary angioedema (HAE) in patients aged 12 years and older.
Nov 14, 2018 - The FDA accepts Shire's (SHPG) sNDA and is expected to take action in March 2019.
Nov 01, 2018 - Shire Plc (NASDAQ:SHPG)Q3 2018 Earnings CallNovember 01, 2018 10:00 am ETExecutivesChristoph Brackmann - Shire PlcFlemming Ornskov - Shire PlcThomas J. W. Dittrich - Shire PlcAnalystsJo Walton - Credi
Oct 10, 2018 - J&J's (JNJ) Stelara induces clinical remission and response in ulcerative colitis patients who had failed prior therapy, per data from a phase III study.
Sep 27, 2018 - Aldeyra Therapeutics' (ALDX) dry eye candidate, reproxalap, achieves early onset of improvement in patients and a broad range of activity.
Sep 21, 2018 - Let's see if Shire plc (SHPG) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Sep 17, 2018 - Companies In The News are:
Sep 10, 2018 - Shire (SHPG) has a strong hold in the attention deficit hyperactivity disorder (ADHD) market despite facing competition.
Jul 11, 2018 - Companies In The News are: